CytoDyn Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies - Litigation (Details)

Commitments and Contingencies - Litigation (Details) $ / shares in Units, shares in Thousands, $ in Thousands							3 Months Ended
	Oct. 04, 2021	Jul. 02, 2021 USD ($)	Jun. 04, 2021 USD ($) shares	Mar. 19, 2021 USD ($) shares	Dec. 15, 2020 item	Nov. 16, 2018 shares	Aug. 31, 2021 USD ($) item $ / shares shares	May 31, 2021 shares
Loss Contingencies [Line Items]
Common stock, shares issued							644,120	626,123
Number Of Lawsuits Consolidated \| item							3
Equity instruments issued in legal settlement, shares							1,600
Equity instruments issued in legal settlement, value \| $							$ 1,744
Warrants for legal settlement, exercise price \| $ / shares							$ 0.40
Warrants for legal settlement, expiration period							7 years
Subsequent Event
Loss Contingencies [Line Items]
Collaborative Arrangement Term	8 years
Michael Klump, Jordan Naydenov And David Welch [Member]
Loss Contingencies [Line Items]
Percentage of awards forfeited			100.00%
Options forfeited			2,250
Scott A Kelly
Loss Contingencies [Line Items]
Percentage of awards forfeited			60.00%
Options forfeited			750
Nader Pourhassan [Member]
Loss Contingencies [Line Items]
Percentage of awards forfeited			100.00%
Warrants forfeited			2,000
Options forfeited			400
Delaware Shareholder Derivative Lawsuit [Member]
Loss Contingencies [Line Items]
Number of independent directors \| item					3
Compensation policy period					5 years
Damages sought \| $				$ 4,100
Amount awarded to other party \| $			$ 3,000
Placement Agent Arbitration Claim [Member]
Loss Contingencies [Line Items]
Legal fees, etc. \| $							$ 200
Equity instruments issued in legal settlement, shares							1,600
Equity instruments issued in legal settlement, value \| $							$ 1,700
Warrants for legal settlement, exercise price \| $ / shares							$ 0.40
Warrants for legal settlement, expiration period							7 years
Pestell Employment Dispute [Member]
Loss Contingencies [Line Items]
Award vesting period						3 years
Stock units granted, shares						8,300
Stock option granted, Shares						400
Prosta Gene Arbitration [Member]
Loss Contingencies [Line Items]
Amount awarded to other party \| $		$ 6,200
Shares subject to arbitration				3,100
Legal fees, etc. \| $		$ 1,400